Hemostatics
Pharmaceutical Manufacturing
Es
10 employees
- Employees
- 10
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Hemostatics Overview
- Headquarters
- Es
- Website
- hemostatics.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 10
- Founded
- 2020
- Funding
- 1.1M
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
About Hemostatics
Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions. Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases).
Hemostatics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Hemostatics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nicolas Saglio | CEO at Hemostatics I Healthcare Venture | Barcelona, Catalonia, Spain |
Email
|
| Jesus M. Hernandez | Biotech & Pharma Consultant |
View
|
|
| Peter Fenici | Head of Medical Innovation at Az | Italy |
Email
Phone
|
| Jeannett Dimsits | VP Development at Minervax, Board | Copenhagen, Capital Region of Denmark, Denmark |
Email
|
Employees by Management Level
VP / Head
2 profiles
Executive
1 profile
Individual contributor
1 profile
Compare Similar Companies to Hemostatics
Parc Científic de Barcelona
Research Services
INBRAIN Neuroelectronics
Technology, Information And Internet
Leanbio S.L.
Biotechnology Research
Kennek
Software Development
Biofabri
Pharmaceutical Manufacturing
Nanobots Therapeutics
Biotechnology Research
Fecundis Lab
Biotechnology
HealthTech180
Venture Capital And Private Equity Principals
WildGrace
Marketing Services
Exostatics Pharmaceuticals
Biotechnology Research